NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live PDS Biotechnology Corporation Common Stock Share Price Chart

O H L

PDS Biotechnology Corporation Common Stock Performance Overview

Days Range
$0.76Low
$0.84High

Markets Today

Previous Close$0.84
Open$0.83
Volume4,490,625
Day's Range$0.76 - $0.84
52W Range$0.20 - $1.55
Market Cap$71.79 M

Historical Performance

1M Returns+304.90
3M Returns-11.81
6M Returns+29.65
1Y Returns-26.77
5Y Returns-94.36
10Y ReturnsNA

PDS Biotechnology Corporation Common Stock Fundamentals

Market Cap$71.79 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-2.44
EPS TTM$-0.65
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-31.52 M
Profit MarginN/A
Market Cap$71.79 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-2.44
EPS TTM$-0.65
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-31.52 M
Profit MarginN/A

PDS Biotechnology Corporation Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$9.11 M-$7.62 M-$8.14 M-$6.67 M-$6.52 M-$6.50 M
EBITDA -$9.10 M-$7.62 M-$8.13 M-$6.67 M-$6.52 M-$6.49 M
Interest Expense -$930.88 K-$2.14 M-$1.15 M-$1.11 M-$1.01 M-$3.38 M
Depreciation $5.46 K$5.46 K$5.46 K$5.46 K$5.46 K$8.39 K
Income Before Tax -$9.66 M-$9.43 M-$9.01 M-$7.56 M-$7.35 M-$9.75 M
Income Tax Expense -$1.17 M$0$0$0$0$0
Net Income +-$8.49 M-$9.43 M-$9.01 M-$7.56 M-$7.35 M-$9.75 M
Net Profit Margin ------

PDS Biotechnology Corporation Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $15.00 K$15.39 K$15.74 K$18.11 K$18.42 K$18.45 K
Reserve & Surplus -$190.60 M-$200.03 M-$209.04 M-$216.61 M-$223.96 M-$233.71 M
Non-Current Liabilities $6.40 M$12.98 M$11.92 M$11.76 M$10.62 M$9.48 K
Current Liabilities $18.27 M$11.53 M$13.33 M$9.48 M$10.15 M$12.38 M
Total Liabilities $24.67 M$24.52 M$25.25 M$21.24 M$20.77 M$12.39 M
Fixed Assets $136.56 K$131.10 K$125.64 K$120.18 K$114.72 K$176.61 K
Current Assets $42.47 M$33.65 M$27.89 M$28.25 M$22.89 M$7.05 M
Total Assets $47.03 M$40.48 M$34.71 M$30.49 M$24.66 M$8.81 M

PDS Biotechnology Corporation Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$8.49 M-$9.43 M-$9.01 M-$7.56 M-$7.35 M-$9.75 M
Operating Cash Flow -$9.03 M-$9.10 M-$5.92 M-$3.70 M-$4.37 M-$2.79 M
Investing Cash Flow $0$0$0$0$0$0
Financing Cash Flow $7.32 M$995.94 K$241.21 K$4.22 M-$679.83 K-$13.27 M
Change in Cash -$1.71 M-$8.11 M-$5.67 M$513.32 K-$5.05 M-$16.06 M

PDS Biotechnology Corporation Common Stock Return Calculator

The PDS Biotechnology Corporation Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$556
Invested Amount$10,000
Est. Returns$-9,444
Invest in USA Stock Today

About PDS Biotechnology Corporation Common Stock

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

FAQs

PDS Biotechnology Corporation Common Stock (PDSB) share price as of September 18, 2026 is $0.83. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the PDS Biotechnology Corporation Common Stock (PDSB) Share by opening an international trading account with Angel One.
Purchasing PDS Biotechnology Corporation Common Stock (PDSB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying PDS Biotechnology Corporation Common Stock (PDSB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of PDS Biotechnology Corporation Common Stock (PDSB) or any other US company shares in Angel One for any dollar amount.
The market capitalization of PDS Biotechnology Corporation Common Stock on September 18, 2026, is $71.79 M.
PDS Biotechnology Corporation Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in PDS Biotechnology Corporation Common Stock (PDSB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91